Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2017

Nov 16, 2017

30291_dirs_2017-11-16_8e4938f1-2c33-4bc1-887a-b3ec68beaff8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2017-11-07

Reporting Person: Guindo Chirfi (EVP Glob. Mkt Acc & Cust Innov)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct